Project list item
[Studies on a novel immunotherapy for bladder cancer by NAD+] - Original in Japanese

Japan Society for the Promotion of Science to 博史 上原, Haruhito AZUMA, Kazumasa Komua

USD 39,508
2019 - 2024
Project list item
[Efficacy and toxicity of bladder instillation of anti-tumor peptide for inhibition of bladder tumor in mice] - Original in Japanese

Japan Society for the Promotion of Science to Toru SHIMAZUI, Hiroyuki NISHIYAMA, Takahiro Kojima, Kazuhiro YOSHIKAWA

USD 39,492
2019 - 2022
Project list item
Combatting Bladder Cancer by Inducing Epithelial Turnover

National Cancer Institute to SOMAN N ABRAHAM

USD 372,404
2019 - 2021
Project list item
Chromatin Modifier Gene Mutation and Enhancer Dysfunction in Bladder Cancer

National Cancer Institute to BYRON H LEE

USD 486,410
2019 - 2024
Project list item
Phase 1/2 Study of Modern Immunotherapy in BCG-Relapsing Urothelial Carcinoma of the Bladder - (ADAPT-BLADDER)

National Cancer Institute to NOAH M HAHN

USD 1,313,632
2019 - 2024
Project list item
Development of an automated method to capture bladder cancer recurrence and progression for epidemiologic research

National Cancer Institute to ANIKET A KAWATKAR, KIM N DANFORTH

USD 382,751
2019 - 2021
Project list item
Cell-biological mechanisms of the urinary bladder multifocal tumor formation (postdoctoral research project)

Slovenian Research Agency to Jerman Urška Dragin

 
2019 - 2021
Project list item
Clonal evolution and molecular stratification of urothelial carcinoma in situ of the urinary bladder

German Research Foundation to Stefan Garczyk, Nadine Gaisa

 
2019 -
Project list item
Mammalian SWI/SNF complexes in urothelial bladder cancer: analysis of the tumorbiological role of ARID1A and identification of potential ARID1A-deficiency-based therapeutic strategies

German Research Foundation to Stefan Garczyk

 
2019 -
Project list item
BCG+MM Trial: Adding mitomycin to BCG as adjuvant intravesical therapy for high-risk, nonâ muscle-invasive bladder cancer: a 2-stage, randomised phase 3 trial.

National Health and Medical Research Council to Dickon Hayne

USD 1,103,245
2019 -
Project list item
The role of a new molecular driver in bladder cancer

National Cancer Institute to DALEY MORERA

USD 90,032
2018 - 2021
Project list item
New therapeutic approaches for non-muscle invasive bladder cancer (NMIBC): intravesical use of OncoTherad biological response modifier and its association with platelet rich plasma (PRP)

São Paulo Research Foundation to Wagner José Fávaro

 
2018 - 2020
Project list item
Urinary microbiota characterization of superficial bladder Cancer patients undergoing BCG immunotherapy

São Paulo Research Foundation to Anamaria Aranha Camargo

 
2018 - 2022
Project list item
Effects of OncoTherad immunotherapy (MRB-CFI-1) on tumor progression and survival of animals with non-muscle invasive bladder cancer (NMIBC): determination of potential mechanisms of action

São Paulo Research Foundation to Wagner José Fávaro

 
2018 - 2019
Project list item
Further Development of Multi-Antigen Vaccines for Primary and Secondary Prevention of Bladder Cancer HHSN2612015000361 TO: HHSN26100011 PP: 9/17/2018 to 3/16/2020

National Cancer Institute to CLINTON GRUBBS

USD 670,206
2018 - 2020
Project list item
Further Development of Multi-Antigen Vaccines for Primary and Secondary Prevention of Bladder Cancer

National Cancer Institute to CLINTON GRUBBS

USD 231,523
2018 - 2020
Project list item
Elucidating immunotherapy resistance mechanisms in non-T cell-inflamed bladder cancer

National Cancer Institute to RANDY F. SWEIS

USD 425,338
2018 - 2022
Project list item
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles

National Cancer Institute to JOE ASSOULINE, YI LUO

USD 350,240
2018 - 2020
Project list item
Novel recombinant BCG for immunotherapy of bladder cancer

National Cancer Institute to BORIS SHOR

USD 290,014
2018 - 2020
Project list item
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer

National Cancer Institute to MIKE GLODE, SHAWN PATRICK ZINNEN

USD 299,937
2018 - 2020
load more...